Reply: Loperamide-Associated Ventricular Arrhythmias.

Krantz, Mori J; Stockbridge, Norman; Kao, David P; Klein, Michael G; Haigney, Mark C P

Krantz, Mori J; Stockbridge, Norman; Kao, David P; Klein, Michael G; Haigney, Mark C P.

Afiliação

Krantz MJ; U.S. Food and Drug Administration, Silver Spring, Maryland, USA. Electronic address: Mori.krantz@fda.hhs.gov.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Kao DP; University of Colorado School of Medicine, Aurora, Colorado, USA.
Klein MG; Uniformed Services University, Cardiology, Bethesda, Maryland, USA.
Haigney MCP; Uniformed Services University, Cardiology, Bethesda, Maryland, USA.

J Am Coll Cardiol ; 82(17): e159, 2023 10 24.

Article em En | MEDLINE | ID: mdl-37852701

Assuntos

Overdose de Drogas; Loperamida; Humanos; Loperamida/efeitos adversos; Arritmias Cardíacas/induzido quimicamente

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Overdose de Drogas / Loperamida Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google